欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是

中国临床药理学与治疗学 ›› 2009, Vol. 14 ›› Issue (2): 191-194.

• 药物治疗学 • 上一篇    下一篇

还原型谷胱甘肽对酒精性肝炎患者肝纤维化指标的影响

周红萍, 庄让笑, 茹仁萍   

  1. 杭州市第六人民医院药剂科, 杭州310014, 浙江
  • 收稿日期:2008-11-06 修回日期:2008-12-22 出版日期:2009-02-26 发布日期:2020-10-30
  • 作者简介:周红萍, 女, 学士, 主管药师, 研究方向:医院药学。Tel:0571-85463948  E-mail:zhouhongping1225@sina.com

Reduced glutathione hormone's impact on alcoholic hepatitis patient's index of hepatic fibrosis

ZHOU Hong-ping, ZHUANG Rang-xiao, RU Ren-ping   

  1. Department of Pharmacy, the Sixth People's Hospital of Hangzhou, Hangzhou 310014, Zhejiang, China
  • Received:2008-11-06 Revised:2008-12-22 Online:2009-02-26 Published:2020-10-30

摘要: 目的:观察酒精性肝炎患者使用还原型谷胱甘肽治疗后肝纤维化指标的改善情况及临床症状、体征、肝功能的变化。方法:将72 例酒精性肝炎患者分成治疗组(37 例) 和对照组(35 例), 对照组给予甘利欣、门冬氨酸钾镁注射液、多种维生素等综合治疗, 治疗组在综合治疗的基础上加用还原型谷胱甘肽(1.5 g, 一日一次), 疗程均为8 周。观察治疗前后两组的血清纤维化指标[ 透明质酸(HA) 、层粘连蛋白(LN) 、Ⅲ型前胶原N 端肽(P Ⅲ-P) 、IV 型胶原(C-IV) ] 及生化指标[ 总胆红素(TBIL) 、ALT 、AST 、γ-谷氨酰转肽酶(GGT) ] 的变化。结果:治疗组在症状、体征、肝功能、血清纤维化的改善方面明显优于对照组, 治疗组血清肝纤维化指标与治疗前相比均有明显下降(P <0.01), 而对照组下降不明显, 两组相比有统计学差异(P <0.01)。结论:还原型谷胱甘肽对酒精性肝炎患者有明显的抗纤维化作用和保肝护肝作用。

关键词: 还原型谷胱甘肽, 酒精性肝炎, 肝纤维化

Abstract: AIM: To observe the changes of hepatic fibrosis index, clinical symptom, physical sign and hepatic function after the patients were treated treatment with reduced glutathione hormone.METHODS: The 72 patients were divided into two groups that one was the treatment group with 37 patients and the other was the control group with 35 patients.The control group was accepted the treatment with Ganlixin Injection, Magnesium Aminosuccinate Injection and Mulvital, etc.The treatment group was accepted reduced glutathione hormone(1.5 g, once a day) in addition. The course of treatment lasted for 8 weeks.We observed the two groups'blood-serum fibrosis indexes (HA, LN, PIII-P, C-IV) and biochemistry indxes (TBIL, ALT, AST, GGT) before and after the treatment.RESULTS: The improvements of the treatment group were much better than the control group on the sides of clinical symptom, physical sign, hepatic function and blood-serum fibrosis.The treatment group's blood-serum fibrosis indexes were much lower after the treatment(P <0.01), and there was no clear decline in the control group.There were obvious differences between the two groups(P <0.01).CONCLUSION: Reduced glutathione hormone has the significant effects of anti-fibrosis and liver protection.

Key words: reduced glutathione hormone, alcoholic hepatitis, hepatic fibrosis

中图分类号: